4
Changes in Ownership
Oruka Therapeutics, Inc. Filed Acc 0000907654-26-000029
General Counsel sold 733 shares at $41.30 ($30,273)
From the SEC's structured data for this filing
Trades in this filing
Quinlan Paul T · General Counsel
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-03-16 | Sale : show line 1 in the form | −733 | $41.30 | $30,273 | 31,767 | D |
| Open-market sales · 733 sh · avg $41.30 · $30,273 | ||||||
Loading xslF345X05/form4.xml…